The major health risks for travelers to developing countries include injuries, malaria, hepatitis A, hepatitis B, rabies, AIDS and travelers’ diarrhea. Most illnesses can be avoided by use of preventive measures including use of seatbelts in cars, hygienic measures and use of effective immunization and chemoprophylaxis. Practitioners of travel medicine need to know the health risks that confront travelers in order to advise which preventive measures should be used. Most available data apply to travelers visiting developing countries.
CartwrightR.Y.Epidemiology of travellers’ diarrhoea. PHLS Microbiology Digest1992; 9, 121–124
9.
PitzingerB.SteffenR.TschoppA.Epidemiology of travelers’ diarrhea in infants and children. J Pediatr Infect Dis1991; 10, 719–723
10.
KozickiM.SteffenR.ScharM.‘Boil it, cook it, peel it or forget it’: does this rule prevent travellers’ diarrhoea?. Int J Epidemiol1985; 14, 169–172
11.
PeltolaH.SiitonenA.KyronseppaH.SimulaI.MattilaL.OksanenP.KatajaM.J.CadozM.Prevention of travellers’ diarrhoea by oral Bsubunit/whole-cell cholera vaccine. Lancet1991; 338, 1285–1289
12.
FarthingM.J.G.DuPontH.L.GuandaliniS.KeuschG.T.SteffenR.Prevention and treatment of travellers’ diarrhoea. Gastroenterology International1992; 5, 162–175
13.
EricssonC.D.DuPontH.L.MathewsonJ.J.Stewart WestM.JohnsonP.C.BitsuraJ.A.M.Treatment of travelers’ diarrhea with sulfamethoxazole and trimethoprim and loperamide. JAMA1990; 263, 257–261
14.
SteffenR.HeusserR.MächlerR.BruppacherR.NaefU.ChenD.HofmannA.M.SomainiB.Malaria chemorophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy. Bull WHO1990; 68, 313–322
Schmid, R.A. Personal protection against malaria, excluding chemoprophylaxis [thesis]. University of Zurich, 1992.
18.
LobelH.O.Phillips-HowardP.A.Brandling-BennettA.D.SteffenR.CampbellC.C.HuongA.Y.WereJ.B.O.Malaria incidence and prevention among European and North American travellers to Kenya. Bull WHO1990; 68, 209–215
19.
SteffenR.FuchsE.SchildknechtJ.NaefU.FunkM.SchlagenhaufP.Phillips-HowardP.NevillCh.StürchlerD.Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet1993; 341, 1299–1303
20.
LobelH.O.BernardK.W.WilliamsS.L.et al.Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. JAMA1991; 265, 361–364
21.
LobelH.O.MianiM.EngT.BernardK.W.HightowerA.W.CampbellC.C.Long-term malaria chemoprophylaxis with mefloquine. Lancet1993; 341, 848–851
22.
Koch, S. and Stetten, R. Occurrence of meningococcal disease in travelers. J Travel Med 1994; 1 (in press).
23.
PangL.W.BoudreauE.F.LimsomwongN.SingharajP.Doxycycline prophylaxis for falciparum malaria. Lancet1987; 2, 1161–1164
24.
WatanasookC.SingharajP.SuriyamongkolV.KarwackiJ.J.ShanksD.PhintuyothinP.PilongkasaS.WasuwatP.Malaria prophylaxis with doxycycline in soldiers deployed to the Thai–Kampuchean border. Southeast Asian J Trop Med Public Health1989; 20, 61–64
25.
SingharajP.EamsilaC.BhothisuwanA.et al.Efficacy of doxycycline as malaria prophylaxis in the soldiers deployed to the Thai–Kampuchean border. R Thai Army Med J1987; 40, 165–170
26.
Magruder, CD., Darby, W., Blaedel, M. and Kelley, P. Effectiveness and utilization of malaria prevention measures among a group traveling to Kenya. In: Program and Abstracts of the Second Conference on International Travel Medicine. Atlanta, GA: 1991. Abstract no. 8.
27.
ShmuklarskyM.J.BoudreauE.F.PangL.W.SmithJ.F.SchneiderI.MilhousW.K.FleckensteinL.AbdelrahimM.SchusterB.Evaluation of doxycycline for causal prophylaxis of Plasmodium falciparumProgram and Abstracts of the 39th Annual Meeting of the American Society for Tropical Medicine and Hygiene, Lawrence, Kan: Allen Press, 1990Abstract no. 343
28.
FrostP.WeinsteainG.D.GomezE.Phototoxic potential of minocycline and doxycycline. Arch Derm1972; 105, 681–683
29.
World Health OrganizationInternational Travel and Health. Geneva: World Health Organization, 1992
30.
SteffenR.Travel medicine – prevention based on epidemiological data. Trans R Soc Trop Med Hyg1991; 85, 156–162
31.
SteffenR.Risk of Hepatitis A in travellers. Vaccine1992; 10(Suppl 1), 569–572
32.
SteffenR.Risk of Hepatitis B for travellers. Vaccine1990; 8, S531–S532
33.
Public Health Laboratory ServicesCommunicable Disease Report. Community Medicine1984; 6, 72–75
34.
SteffenR.Typhoid vaccine, for whom?. Lancet1982; i, 615–616
35.
TaylorD.N.PollardR.A.BlakeP.A.Typhoid in the United States and the risk to the international travelers. J Infectious Diseases1983; 148, 599–602
36.
MorgerH.SteffenR.SchärM.Epidemiology of cholera in travellers and conclusions for vaccination recommendations. BMJ1983; 286, 184–186
37.
SnyderJ.D.BlakeP.A.Is cholera a problem for US travelers?. JAMA1982; 247, 2268–2269
38.
DigoutteJ.P.PlassartH.SalaunJ.J.HemeG.FerraraL.GermainM.A propos de trois cas de fièvre jaune contractée au Sénégal. Bull WHO1981; 59, 759–766
